Atopic and nonatopic IgE-mediated allergy: A new interpretation of old facts?

International Archives of Allergy and Immunology

Volumn 129, Issue 2, 2002, Pages 97-107

  De Weck, Alain L ^a,b  

^a Gerimmun Foundation   (Switzerland)

^b NONE   (Switzerland)

Author keywords

Allergic breakthrough; Allergy prevention; Atopy; High IgE responders; IgE; Low IgE responders; Non atopic allergy

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; POLLEN ANTIGEN;

ALLERGIC ASTHMA; ATOPY; CHROMOSOME; DERMATOPHAGOIDES PTERONYSSINUS; DOG; FAMILIAL DISEASE; GENETIC DISORDER; HAY FEVER; HUMAN; IMMUNE MEDIATED INJURY; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHINOCONJUNCTIVITIS; T LYMPHOCYTE;

ALLERGENS; ANIMALS; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E;

EID: 0036974398     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065874     Document Type: Review

References (100)

1. Schadewaldt H: Zur Geschichte des Begriffes 'Atopie'. Krankenhausarzt 1980;3:169-173.
2. Coca A, Cooke RA: On the classification of the phenomenon of hypersensitiveness. J Immunol 1923;8:163-182.
3. Prausnitz C, Küstner H: Studien über die Überempfindlichkeit. Zentralbl Bakteriol Parasitenkol Infektionskt Abt. I Originale 1921;86:160-169.
4. Coca A, Grove EF: Studies in hypersensitiveness. XIII. A study of the atopic reagins. J Immunol 1925;10:445-464.
5. Wise F, Sulzberger MB: Footnote on problem of eczema, neurodermatitis and lichenification; in Wise F, Sulzberger MB (eds): The 1933 Yearbook of Dermatology and Syphilology. Chicago, Year Book 1933, pp 38-39.
6. Ishizaka K, Ishizaka T: Identification of γE antibodies as carrier of reaginic activity. J Immunol 1967;99:1187-1198.
7. Johansson SGO: Raised levels of a new immunoglobulin (IgND) in asthma. Lancet 1967;ii:951-953.
8. Pepys J: Atopy; in Gill PGH, Coombs RRA, Lachmann PJ (eds): Clinical Aspects of Immunology, ed 3. Oxford, Blackwell Scientific, 1975, pp 877-902.
9. Ring J: Atopy; in Ruzicka T, Ring J, Przybilla B (eds): Condition, disease or syndrome? Handbook of Atopic Eczema. Springer, Berlin, 1991; pp 3-8.
10. Spector SL, Farr RS: Atopy reconsidered. Clin Allergy 1976;6:83-90.
11. Wüthrich B: What is atopy? Condition, disease or a syndrome? in Wüthrich B (ed): The Atopy Syndrome in the Third Millenium. Curr Probl Dermatol. Basel, Karger, 1999, vol 28, pp 1-8.
12. WHO Workshop Panel Proceedings. Recognition of the Atopic Status, Florence, June 1984. Clin Allergy 1986;16(suppl 1):19-26.
13. Johansson SG, Hourihane JO, et al: A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824.
14. Bousquet J, Hejjaoui A, Becker W, et al: Clinical and immunological reactivity of patients allergic to grass pollens and to multiple pollen species I. Clinical and immunological characteristics. J Allergy Clin Immunol 1991;87:737-746.
15. Bousquet J, Pène J, Michel FB: Heterogeneity of atopy. Allergy Clin Immunol News 1992;4:49-53.
16. Pène J, Rivier A, Michel FB, Bousquet J: Heterogeneity of atopy demonstrated by differences in cytokine release by peripheral blood T cells. J Allergy Clin Immunol 1992;89:174.
17. De Weck AL: What can we learn from the allergic zoo? Int Archs Allergy Immunol 1997;113:55-57.
18. Cooke RA, van der Veer A: Human sensitization. J Immunol 1916;1:201-305.
19. Duffy DL, Martin NG, Battistuta D, Hopper JL, Matthews JD: Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 1990;142:1351-1358.
20. Duffy DL, Mitchell CA, Martin NG: Genetic and environmental risk factors for asthma: A cotwin-control study. Am J Respir Crit Care Med 1998;157:840-845.
21. Hanson B, McGue M, Roitman-Johnson B, et al: Atopic disease and immunoglobulin E in twins reared apart and together. Am J Hum Genet 1991;48:873-879.
22. Schultz-Larsen F, Holm NV, Henningsen K: Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487-494.
23. Schultz-Larsen F: Atopic dermatitis: A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993;28:719-723.
24. Strachan DP, Wong HJ, Spector TD: Concordance and interrelationship of atopic diseases and markers of allergic sensitization among adult female twins. J Allergy Clin Immunol 2001;108:901-907.
25. Castro J, Telleria JJ, Blanco-Quiros A: Susceptibility genes for asthma and allergy: Quiz and questions. J Invest Allergol Clin Immunol 2001;11:73-78.
26. Cookson WOCM: The genetics of atopic dermatitis: Strategies, candidate genes and genome screens. J Am Acad Dermatol 2001;45:S7-S9.
27. Holgate ST, Bleeker ER, Meyers DA, Kaprio J, Martinez F: The genetics of asthma: Methodological approaches. Clin Exp Allergy 1998;28(suppl 1):1-116.
28. Koppelman GH, Stine OC, Xu J, Howard TD, Zheng SL, Kauffman HF, Bleecker ER, Meyers DA, Postma DS: Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol 2002;109:498-506.
29. Cookson WO, Sharp PA, Faux JA, Hopkin JM: Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11 q. Lancet 1989;i:1292-1295.
30. Marsh DG, Meyers DA, Bias WB: The epidemiology and genetics of atopic allergy. N Engl J Med 1981;305:1551-1559.
31. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, et al: Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-1156.
32. Vabres P: Dermatite atopique: Données génétiques actuelles. Rev Fr Allergol Immunol Clin 2002;42:317-321.
33. Sandford AJ, Weir TD, Paré PD: Phenotypic heterogeneity in asthma and allergy. Clin Exp Allergy 1998;28(suppl 1):26-31.
34. Vercelli D: The functional genomics of CD 14 and its role in IgE responses: An integrated view. J Allergy Clin Immunol 2002;109:14-21.
35. Patterson R: Laboratory models of reaginic allergy. Prog Allergy 1969;13:322-407.
36. Puel A, Mevel JC, Bouthillier Y, Feingold N, Fridman WH, Mouton D: Toward genetic dissection of high and low antibody reponsiveness in Biozzi mice. Proc Natl Acad Sci USA 1996;93:14742-14746.
37. Levine BB, Vaz NM: Effect of combinations of inbred strain, antigen and antigen dose on immune responsiveness and reagin production in the mouse. Int Arch Allergy Appl Immunol 1970;39:156-171.
38. Watanabe N, Kojia S, Ovary Z: Suppression of IgE antibody production in SJL mice. I. Non-specific suppressor T cells. J Exp Med 1976;143:833-845.
39. Chiorazzi N, Fox DA, Katz DH: Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE 'non-responder' strains to IgE 'responders' by elimination of suppressor T cell activity. J Immunol 1977;118:48-54.
40. Holt PG, Clough JB, Holt BJ, et al: Genetic 'risk' for atopy is associated with delayed post-natal maturation of T cell competence. Clin Exp Allergy 1992;22:1093-1099.
41. Katz DH: The allergic phenotype: Manifestation of allergic breakthrough and imbalance in normal damping of IgE antibody production. Immunol Rev 1978;41:77-107.
42. Katz DH: Neue Zugänge zur Immuntherapie der IgE-vermittelten allergischen Erkrankungen. Krankenhausarzt 1980;53:188-194.
43. Katz DH: IgE antibody responses in vitro from rodents to man. Prog Allergy 1982;32:105-160.
44. Okumura K, Tada T: Regulation of homocytotropic antibody formation in the rat. VI. inhibitory effect of thymocytes on the homocytotropic antibody response. J Immunol 1971;107:1682-1689.
45. Sedgwick JD, Holt PG: Induction of IgE-secreting cells and IgE isotype-specific suppressor T cells in the respiratory lymph nodes of rats in response to antigen inhalation. Cell Immunol 1985;94:182-194.
46. Tada T: Regulation of reaginic antibody formation in animals. Prog Allergy 1975;19:122-194.
47. Mori A, Yamamoto K, Suko M, Watanabe N, Ito M, Miyamoto T, Okudaira H: Interleukin-4 gene expression in high and low IgE responder mice. Int Arch Allergy Appl Immunol 1990;92:100-102.
48. De Weck AL, Derer M, Mayer P, Stumper B: Allergy starts in early life: Clinical and experimental evidence; in Sasaki S, Miyamoto T, Hopkin JM (eds): Prediction and Prevention of Childhood Allergy. Osaka, Churchill-Livingstone, 1995, pp 181-187.
49. De Weck AL: Dog allergy: A model for allergy genetics. Int Arch Allergy Immunol 1997;113:55-57.
50. De Weck AL, Derer M, Mayer P, Liehl E, Schiessl B, Zunic M, Schneider H: Neuere genetische und pathogenetische Aspekte der Atopie. Allergologie 1999;22:92-97.
51. De Weck AL, Griot-Wenk M, Schneider H, Schiessl B, Zeemann B, Mayer P, Liehl E: Human allergogeneticists should listen to their dog's barking; in Ring J, Behrendt H (eds): Trends in Allergy V, in press.
52. Schiessl B, Zemann B, Hodgin-Pickart LA, de Weck AL, Mayer P, Nefzger M, Schneider H, Liehl E: Importance of early allergen contact for the development of sustained immunoglobulin E response in Beagle dogs, submitted.
53. Frick OL: Food allergy in atopic dogs. Adv Exp Med Biol 1996;409:1-7.
54. Pinckard RN, Halonen M, Meng AL: Preferential expression of anti-bovine serum albumin IgE homocytotropic antibody synthesis and anaphylactic sensitivity in the neonatal rabbit. J Allergy Clin Immunol 1972;49, 301.
55. Björksten B: The intrauterine and postnatal environments. J Allergy Clin Immunol 1999;104:1119-1127.
56. Jones AC, Miles EA, Warner JO, Colwell BM, Bryant TN, Warner JA: Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 1996;7:109-116.
57. Piccini MP, Mecacci F, Sampognaro S, et al: Aeroallergen sensitization can occur during fetal life. Int Arch Allergy Immunol 1993;102:301-303.
58. Prescott SL: The significance of immune responses to allergens in early life. Clin Exp Allergy 2001;31:1167-1169.
59. Szepfalusi Z, Nentwich I, Gerstmayr M, Jost E, Toloran L: Prenatal allergen contact with milk proteins. Clin Exp Allergy 1997;27:28-35.
60. Szepfalusi Z, Loibichler C, Pichler J, Reisenberger K, Ebner C, Urbanek R: Direct evidence for transplacental allergen transfer. Pediatr Res 2000;48:404-407.
61. Warner JA, Jones CA, Jones AC, Warner JO: Prenatal origins of allergic disease. J Allergy Clin Immunol 2000;105:493-498.
62. Williams TJ, Jones CA, Miles EA, Warner JO, Warner JA: Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J Allergy Clin Immunol 2000;105:951-959.
63. Björksten B, Sepp E, Julge K, Voor T, Mikelsaar M: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-520.
64. Holt PG, Sly PD, Björksten B: Atopic versus infectious diseases in childhood: A question of balance? Pediatr Allergy Immunol 1997;8:53-58.
65. Holt PG, Macaubas C, Prescott SL, Sly PD: Microbial stimulation as an aetiologic factor in atopic children. Allergy 1999;54(suppl 49):12-16.
66. Liu AH: Endotoxin exposure in allergy and asthma: Reconciling a paradox. J Allergy Clin Immunol 2002;109:379-392.
67. McKeever TM, Lewis SA, Smith C, Collins J, Heatlie H, Frischer M, Hubbard R: Early exposure to infections and the incidence of allergic disease: A birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol 2002;109:43-50.
68. Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, Holt PJ: Transplacental priming of the human system to environmental allergens: Universal skewing of initial T cell responses towards the Th2 cytokine profile. J Immunol 1998;160:4730-4737.
69. Shirikawa T, Enomoto T, Shimazu S, Hopkin JM: The inverse association between tuberculin responses and atopic disorders. Science 1997;275:77-79.
70. Schrander JJ, Poudsen S, Forget PP, Kuijten RH: Follow up study of cow's milk protein intolerant infants. Eur J Pediatr 1992;151:783-785.
71. Renz H, von Mutius E, Illi S, Wolkers F, Hirsch T, Welland SK Th1/Th2 immune response profiles differ between atopic children in eastern and western Germany. J Allergy Clin Immunol 2002;109:338-342.
72. Schäfer T: Neues zur Epidemiologie des atopischen Ekzems im Kindesalter. Allergologie 2002;25:248-255.
73. Rook GAW, Stanford JL: Give us this day our daily germs. Immunol Today 1998;19:113-116.
74. Cross ML, Gill HS: Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies. Int Arch Allergy Immunol 2001;125:112-119.
75. Herz U, Gerhold K, Gruber C, Braun A, Wahn U, Renz H, Paul K: BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998;102:867-874.
76. Holt PG, Rudin A, Macaubas C, Holt BJ, Rowe J, Lob R, Sly PD: Development of immunological memory against tetanus toxoid and pertactin antigens from the diphteria-tetanus-pertussis vaccine in atopic versus non-atopic children. J Allergy Clin Immunol 2000;105:1117-1122.
77. Tulic MK, Wale JL, Holt PG, Sly PD: Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000;22:604-612.
78. Aramaki Y, Fujii Y, Suda H, Suzuki I, Yadomae T, Tsuchiya S: Induction of oral tolerance by feeding of ragweed pollen extract in mice. Immunol Lett 1994;40:21-25.
79. Clarke CJ, Stokes CR: The intestinal and serum humoral immune response of mice to systemically and orally administered antigens in liposomes. I. The response to liposome-entrapped soluble proteins. Vet Immunol Immunopathol 1992;32:125-138.
80. Deplazes P, Penhale WJ, Greene WK, Thompson RCA: Effect on humoral response (IgG and IgE) in dogs by oral administration of ovalbumin and Der p 1. Vet Immunol Immunopathol 1995;45:361-367.
81. Fanta C, Bohle B, Hirt W, Siemann U, Horak F, Kraft D, Ebner H, Ebner C: Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa or sublingual immunotherapy. Int Arch Allergy Immunol 1999;120:218-224.
82. Pecquet S, Pfeifer A, Gauldie S, Fritsche R: Immunoglobulin E suppression and cytokine modulation in mice orally tolerized to beta-lactoglobulin. Immunology 1999;96:278-285.
83. Yasue M, Yokota T, Kajiwara Y, Suko M, Okudaira H: Inhibition of airway inflammation of rDer f 2-sensitized mice by oral administration of recombinant Der f 2. Cell Immunol 1997;181:30-37.
84. De Weck AL, Griot-Wenk M, Schneider H, Schiessl B, Mayer P, Liehl E: Induction of oral tolerance during the first months of life; in Ring J, Darsow U (eds): 'Allergie 2000: Probleme, Strategien und praktische Konsequenzen'. München, Dustri-Verlag, 2001, pp 264-266.
85. Zemann B, Schwaerzler C, Griot-Wenk M, Nefzger M, Mayer P, Schneider H, de Weck A, Carballido J, Liehl E: Oral tolerance in IgE high responder dogs: Suppression of disease symptoms and enhanced release of anti-inflammatory cytokines, submitted.
86. Holt PG: Development of sensitization versus tolerance to inhalant allergens during early life. Pediatr Pulmonol Suppl 1997;16:6-7.
87. Friedman A, Weiner H: Induction of anergy or active suppression following oral tolerance determined by antigen dosage. Proc Natl Acad Sci USA 1994;91:6688-6692.
88. Schäfer T, Böhler E, Ruhdorfer S, Weigl L, Wessner D, Heinrich J, Filipiak B, Wichmann HE, Ring J: Epidemiology of food allergy/food intolerance in adults: Association with other manifestations of atopy. Allergy 2001;56: 1172-1179.
89. Reid MJ, Schwietz LA, Whismann BA, Moss RB: Mountain cedar pollinosis: Can it occur in non-atopics? N Engl Reg Allergy Proc 1988;9:225-232.
90. Yoo TJ, Kuo CY: Cellular and reaginic immune responses to ragweed antigen E in inbred rats. Int Archs Allergy Appl Immunol 1980;61:259-270.
91. Katz DH, Bargatze RF, Bogowitz CA, Katz LR: Regulation of IgE antibody production by serum molecules. V. Evidence that coincidental sensitization and imbalance in the normal damping mechanism results in 'allergic breakthrough'. J Immunol 1979;122:2191-2197.
92. Katz DH: Regulation of the IgE system: Experimental and clinical aspects. Allergy 1984;39:81-106.
93. Ishizaka K: Cellular events in the IgE antibody response. Adv Immunol 1976;23:1-75.
94. Ishizaka K: Mechanismen der IgE Anti-körper-Reaktion. Krankenhausarzt 1980;53:178-187.
95. Katz DH, Bargatze RF, Bogowitz CA, Katz LR: Regulation of IgE antibody production by serum molecules. VII. The IgE-selective damping damping activity of suppressive factor of allergy (SFA) is exerted across both strain and species specific barriers. J Immunol 1980;124:819-824.
96. Katz DH: The IgE antibody system is coordinately regulated by FcR epsilon-positive lymphoid cells and IgE-selective soluble factors. Int Arch Allergy Appl Immunol 1985;77:21-25.
97. Watanabe N, Ovary Z: Suppression of IgE production in SJL mice. III. Characterization of a suppressor substance extracted from normal SJL spleen cells. J Exp Med 1977;145:1501-1510.
98. Finkelman FD, Katona IM, Urban JF, Holmes JJ, Ohara J, Tung AS, Sample JG, Paul WE: IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988;141:2335-2441.
99. Romagnani S: The Th1 / Th2 paradigm and allergic disorders. Allergy 1998;53(suppl 46):12-15.
100. Murray AB, Morrison BJ: It is children with atopic dermatitis who develop asthma more frequently if the mother smokes. J Allergy Clin Immunol 1990;86:732-739.